Scientific
research
at
rapid
speed.
Get Started
Get Started
OUR MISSION
Rexis™
is
more
than
a platform
for DeSci,
it is a commitment
to
the life
sciences -
a project designed
to
push
the
pace
of
discovery and
innovation
in
biomed
further
than
any
other
catalyst
today.
Rexis™ provides the first entirely encrypted data sharing network for sensitive Biomed datasets.
On a platform where medical institutions can securely compute local gradient updates on their own models.
Through a verification protocol enabling the evaluation of fully encrypted algorithms on patient records.
Rexis™ executes private AI inference on fine-tuned models unique to the causes that matter the most.
THE REXIS EDGE
The complete
solution
for
biomed data.
Data Aggregation and Containerization

Submitted data on Rexis is encrypted end-to-end and containerized by smart contract, aggregated across a diverse set of biomedical data modalities.

Data Training and Finetuning

Rexis facilitates privacy-preserving finetuning and secure clustering of encrypted models across institutions without exposing raw data.

Data Verification and Inference

Rexis executes automated evaluation assessments of the performance of trained models on encrypted data across all supported modalities.

THIS IS REXIS
Changing how research happens.
Data Submission
Hospitals, research labs, pharmaceutical companies, and end users contribute encrypted biomedical datasets to a decentralized data marketplace, with tokenized access control.
Data Rewards
All data contributors receive a unique key and wallet upon submission of their dataset, into which payments are deposited instantaneously when datasets are used for training on the platform.
Data Privacy
All data submitted remains encrypted end-to-end, from point of upload through to training and even through inference. Rexis is the first platform in the world to remain 100% encrypted.
Data Tracking
Data submitted to Rexis is first encrypted, and then uniquely indexed and fingerprinted, so that all data usage by customers training on the platform is tracked for data owner payment.
Data Submission
Hospitals, research labs, pharmaceutical companies, and end users contribute encrypted biomedical datasets to a decentralized data marketplace, with tokenized access control.
Data Rewards
All data contributors receive a unique key and wallet upon submission of their dataset, into which payments are deposited instantaneously when datasets are used for training on the platform.
Data Privacy
All data submitted remains encrypted end-to-end, from point of upload through to training and even through inference. Rexis is the first platform in the world to remain 100% encrypted.
Data Tracking
Data submitted to Rexis is first encrypted, and then uniquely indexed and fingerprinted, so that all data usage by customers training on the platform is tracked for data owner payment.
E-commerce
Seamless shopping experience tailored for eco-conscious brands. terra–tory™ makes commerce feel natural.
Performance
terra–tory™ delivers fast, efficient loading, making your eco-conscious content effortlessly accessible and impactful.
Responsive
Crafted to look perfect on every device, terra–tory™ ensures your sustainable message everyone.
Eco-SEO
Ethical, eco-friendly SEO practices designed to grow your reach while staying true to sustainable values.
Design
Built with sustainability at its core, terra–tory™ minimizes environmental impact without compromising on style.
Aesthetics
Experience a design as forward-thinking as your vision. terra–tory™ blends beauty with purpose.

Rexis™ is latin for "Kings" paying homage to the period of history that precedes modern day medicine. There has been a class-based dichotomy in quality and access to treatment that has existed since the beginning of time. Rexis exists to make Kings of every human on earth through the first decentralized sciences platform.

Today, breakthroughs in medicine, healthcare, and bio sciences are brought to market typically over the course of a decade or longer. It's how it's always been. But we now live in an age where resources are abundant, access to AI is open to all, and technology has the potential to solve some of the most challenging problems that we once faced. Rexis exists to bring biomedical research and development to market at breakneck speed through the first vertically integrated, end-to-end encrypted medical data, fine-tuning and inference platform.

Get Started
Get Started
THE STATISTICS THAT FOUNDED REXIS

The systemic issues in the biomedical industry today.

A WASTED OPPORTUNITY

<0.01%

of global biodata used in collaborative research
MASSIVE COSTS

$2.3 billion

Average cost to bring a drug to market in 2025
A VERY SLOW PACE OF INNOVATION

>10.5 years

Average time to go from Phase 1 to Regulatory Approval
crafted for businesses
A diverse
set
of
biomedical
modalities.
Biomedical Signals
Including electrocardiograms (ECG), photoplethysmograms (PPG), electroencephalograms (EEG), and wearable sensor data.
Tabular Data
Including electronic health records, and clinical trial data.
Biological Sequences
Including genomic sequences (DNA, RNA), and proteomic sequences.
Medical Imaging
Including radiography (X-rays), pathology, ophthalmology, and dermatology.
HOW RESEARCH LEADERS feel ABOUT REXIS
Industry Excitement

"When data related to research activities are shared ethically, equitably, and efficiently, there are major gains for science and public health."

Dr. Soumya Swaminathan
Chief Scientist, World Health Organization

"So much medical data is just sitting there, waiting for possible applications. I got into this space to create real opportunities for impact."

Dr. Andrew Ng
AI Pioneer and Stanford Adjunct Professor

"The success of the project and the commitment to share all of the data rapidly and freely have revolutionized every aspect of human biomedical research and medical practice."

Dr. Francis Collins
Director of NIH and Leader of the
Human Genome Project

"All the applications in our portfolio will ultimately have an AI model. It’s inevitable. Predictive models can help inform physicians and reduce their cognitive burden, which is transformative for wellness and quality of care."

Dr. Gary Fritz
Vice President of Stanford
Health Care

"When data related to research activities are shared ethically, equitably, and efficiently, there are major gains for science and public health."

Dr. Soumya Swaminathan
Chief Scientist, World Health Organization

"So much medical data is just sitting there, waiting for possible applications. I got into this space to create real opportunities for impact."

Dr. Andrew Ng
AI Pioneer and Stanford Adjunct Professor

"The success of the project and the commitment to share all of the data rapidly and freely have revolutionized every aspect of human biomedical research and medical practice."

Dr. Francis Collins
Director of NIH and Leader of the
Human Genome Project

"All the applications in our portfolio will ultimately have an AI model. It’s inevitable. Predictive models can help inform physicians and reduce their cognitive burden, which is transformative for wellness and quality of care."

Dr. Gary Fritz
Vice President of Stanford
Health Care
GET STARTED WITH REXIS
Unleash your scientific research with Rexis.